Concepedia

Lourdes Garcia‐Quintanilla

LG

4

Publications

116

Citations

4

H-Index

2020

Active since

Affiliations

University of Birmingham(Current)

Umm al-Qura University

Lourdes Garcia‐Quintanilla is an author at University of Birmingham specializing in signal transduction, drug discovery, and molecular signaling.

ORCID

Top concepts

Publications per year

2020–2024

4

Publications

4

Low-dose Btk inhibitors selectively block platelet activation by CLEC-2

Phillip L.R. Nicolson, Sophie H. Nock, Joshua Hinds et al. · Haematologica · 2020 · 60 citations · Full text

, , +18

Antiprothrombin antibodies induce platelet activation: A possible explanation for anti‐FXa therapy failure in patients with antiphospholipid syndrome?

Walid Chayouâ, Phillip L.R. Nicolson, Joost C.M. Meijers et al. · Journal of Thrombosis and Haemostasis · 2021 · 28 citations · Full text

The Btk inhibitor AB‐95‐LH34 potently inhibits atherosclerotic plaque–induced thrombus formation and platelet procoagulant activity

Christopher W. Smith, Maan H. Harbi, Lourdes Garcia‐Quintanilla et al. · Journal of Thrombosis and Haemostasis · 2022 · 15 citations · Full text

Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2, and PRN473 reduces venous thrombosis formation in mice

Christopher W. Smith, Joana Campos, Helena Brown et al. · Blood Advances · 2024 · 13 citations · Full text

Rows per page

1–4 of 4